LBF20107PG11: Difference between revisions
No edit summary |
No edit summary |
||
(17 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR1737 | |LipidBank=XPR1737 | ||
|LipidMaps=LMFA03010055 | |LipidMaps=LMFA03010055 | ||
|SysName= 9- | |SysName=9-Oxo- (11alpha,15R) -dihydroxy-prost-trans-13-en-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin E1 | |Common Name=&&15R-Prostaglandin E_1&&9-Oxo- (11alpha,15R) -dihydroxy-prost-13(E)-en-1-oic acid&& | ||
|Source= | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
|Biological Activity=15(R)-Prostaglandin E1 dosen't have biological significance but inhibit 15-hydroxy PGDH (IC50 value of 189 mu M).[[Reference:Jarabak_J:Braithwaite_SS:,Arch. Biochem. Biophys.,1976,177,245|{{RelationTable/GetFirstAuthor|Reference:Jarabak_J:Braithwaite_SS:,Arch. Biochem. Biophys.,1976,177,245}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 08:10, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1737 |
LipidMaps | LMFA03010055 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20107PG11 |
15R-Prostaglandin E1 | |
---|---|
Structural Information | |
9-Oxo- (11α,15R) -dihydroxy-prost-trans-13-en-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
15(R)-Prostaglandin E1 dosen't have biological significance but inhibit 15-hydroxy PGDH (IC50 value of 189 mu M). Jarabak_J et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|